Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...
We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback